Kidney damage associated with anti-phospholipid syndrome
Journal Title: Нирки - Year 2019, Vol 8, Issue 3
Abstract
Antiphospholipid syndrome (APS) is a common autoimmune disease caused by pathogenic antiphospholipid antibodies, leading to recurrent thrombosis and/or obstetric complications. It is important for nephrologists to know that the combination of the antiphospholipid antibody presence associating with various clinical manifestations of kidney damage caused by thrombosis of large renal vessels, renal artery stenosis and intrarenal lesions leads to the antiphospholipid nephropathy development. This condition is associated with acute thrombotic microangiopathy of varying severity, proliferative and fibrous lesions of the intrarenal vessels and ischemic changes in the renal parenchyma. The course of the disease can range from slow progressive nephropathy to life-threatening acute renal failure. The development of secondary antiphospholipid nephropathy associated with antiphospholipid antibodies in the context of systemic lupus erythematosus is the most studied and widely known. In contrast, the clinical significance of isolated antiphospholipid nephropathy remains uncertain and poorly understood. The evidence base for drugs aimed at treating renal complications of APS is limited. However, the recent recognition of heterogeneous molecular mechanisms underlying the progression of intrarenal vascular lesions in APS has opened up promising ways for monitoring patients and target therapeutic interventions.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina, D. G. Rekalov
Keywords
Related Articles
- EP ID EP630029
- DOI 10.22141/2307-1257.8.3.2019.176455
- Views 87
- Downloads 0
Capabilities and benefits of nuclear imagine (scintigraphy) for the assessment of anatomic and topographic and functional state of kidneys in congenital anomalies
The article discusses the possibility of static and dynamic radionuclide imaging in the diagnostics of anomalies and evaluation of the functionality of abnormal kidney. It presents the advantages, disadvantages and possi...
Hypoxia — a Leading Factor of Chronic Kidney Disease Progression
Recent data indicate the involvement of hypoxia in the formation of kidney fibrosis and progression of chronic renal disease. One of the main factors in the chain of damage in the tissue oxygen deficiency is a hypoxia-in...
Chronic Kidney Disease and Ecology
The review of literature presented the relationship between the development of chronic kidney disease with the ecological state of areas of residence of patients, the impact of xenobiotics (inorganic and organic chemical...
Clinical case of successful treatment of Goodpasture syndrome with rituximab
.
Renin angiotensin-aldosterone system blockers: chronic kidney disease and cardiovascular risk
Reducing the risk of cardiovascular events is one of the most topical issues of modern medicine. Patients with chronic kidney disease stage 3 or lower, according to international guidelines, refer to the group with high...